Skip to content
The Longevity Archive
Setmelanotide in all countries

Legal status · United Kingdom

Is Setmelanotide legal in the United Kingdom?

Approved medicineMelanocortinEvidence: Strong

Yes. Setmelanotide is an approved medicine in the United Kingdom, classified as "Licensed, prescription only (MHRA)". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.

Setmelanotide in the United Kingdom at a glance

ClassificationLicensed, prescription only (MHRA)
MHRA approval statusApproved by MHRA for its labeled use
Evidence levelStrong (research strength: Strong)
ReviewedSep 2026

Classification and note come from the Setmelanotide profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.

What this means

  • 01

    MHRA has approved Setmelanotide for at least one labeled indication, so a pharmaceutical-grade product exists in the United Kingdom and is dispensed on prescription.

  • 02

    Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.

  • 03

    Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.

What Setmelanotide is

An FDA-approved MC4R agonist for rare genetic forms of obesity driven by defects in the melanocortin pathway.

Setmelanotide is a selective MC4R agonist approved as Imcivree for obesity caused by specific rare genetic deficiencies (POMC, PCSK1, and LEPR) and for Bardet-Biedl syndrome. It restores signaling in a pathway central to appetite regulation and produces meaningful weight loss in these targeted populations.

Mechanism: Selectively agonizes the melanocortin-4 receptor (MC4R) to restore satiety signaling disrupted by upstream genetic defects.

Regulatory history: FDA-approved (Imcivree) for specific genetic obesity indications

How MHRA treats this kind of product

Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.

The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Setmelanotide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Setmelanotide in other countries

Frequently asked questions

Is Setmelanotide legal in the United Kingdom?

Yes. Setmelanotide is an approved medicine in the United Kingdom, classified as "Licensed, prescription only (MHRA)". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.

Can I buy Setmelanotide in the United Kingdom?

Only with a prescription. Setmelanotide is classified as "Licensed, prescription only (MHRA)" in the United Kingdom, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.

Is Setmelanotide MHRA approved?

Yes, for its labeled indication. In the United Kingdom Setmelanotide is classified as "Licensed, prescription only (MHRA)". For comparison, the US FDA status is: FDA-approved (Imcivree) for specific genetic obesity indications. Evidence level: Strong.

Related compounds in the United Kingdom

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Setmelanotide live on its compound profile.

Setmelanotide profile

This page is general information about the regulatory status of Setmelanotide in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.